首页> 外文期刊>International Journal of Vascular Medicine >Should Endovascular Repair Be Reimbursed for Low Risk Abdominal Aortic Aneurysm Patients? Evidence from Ontario, Canada
【24h】

Should Endovascular Repair Be Reimbursed for Low Risk Abdominal Aortic Aneurysm Patients? Evidence from Ontario, Canada

机译:低风险的腹主动脉瘤患者是否应该报销血管内修复?来自加拿大安大略省的证据

获取原文
           

摘要

Background. This paper presents unpublished clinical and economic data associated with open surgical repair (OSR) in low risk (LR) patients and how it compares with EVAR and OSR in high risk (HR) patients with an AAA > 5.5 cm.Design. Data from a 1-year prospective observational study was used to compare EVAR in HR patients versus OSR in HR and LR patients.Results. Between 2003 and 2005, 140 patients were treated with EVAR and 195 with OSR (HR: 52; LR: 143). The 1-year mortality rate with EVAR was statistically lower than HR OSR patients and comparable to LR OSR patients. One-year health-related quality of life was lower in the EVAR patients compared to OSR patients. EVAR was cost-effective compared to OSR HR but not when compared to OSR LR patients.Conclusions. Despite a similar clinical effectiveness, these results suggest that, at the current price, EVAR is more expensive than open repair for low risk patients.
机译:背景。本文介绍了低危(LR)患者中与开放手术修复(OSR)相关的未发表的临床和经济数据,以及与AAA> 5.5?cm的高危(HR)患者进行的EVAR和OSR的比较。一项为期1年的前瞻性观察研究的数据用于比较HR患者的EVAR与HR和LR患者的OSR。在2003年至2005年之间,140例患者接受了EVAR治疗,195例接受了OSR治疗(HR:52; LR:143)。 EVAR的1年死亡率在统计学上低于HR OSR患者,与LR OSR患者相当。与OSR患者相比,EVAR患者的一年健康相关生活质量较低。与OSR HR相比,EVAR具有成本效益,但与OSR LR患者相比则无济于事。尽管具有相似的临床效果,但这些结果表明,以目前的价格,EVAR的价格比低风险患者的开放式修理更为昂贵。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号